tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Hutchmed announces approval of NDA for Orpathys, Tagrisso combination in China
PremiumThe FlyHutchmed announces approval of NDA for Orpathys, Tagrisso combination in China
1M ago
Hutchmed, Innovent jointly announce NDA acceptance in China
Premium
The Fly
Hutchmed, Innovent jointly announce NDA acceptance in China
2M ago
Hutchmed downgraded to Hold from Buy at HSBC
Premium
The Fly
Hutchmed downgraded to Hold from Buy at HSBC
3M ago
Hutchmed reports FY24 EPS 22c vs. 59c last year
PremiumThe FlyHutchmed reports FY24 EPS 22c vs. 59c last year
5M ago
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
Premium
The Fly
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
5M ago
Hutchmed completes enrollment of fanregratinib trial
Premium
The Fly
Hutchmed completes enrollment of fanregratinib trial
5M ago
Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
PremiumThe FlyMorning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
7M ago
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
Premium
The Fly
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
7M ago
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
Premium
The Fly
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100